لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: S. Peters, J.-L. Pujol, U. Dafni, M. Dómine, S. Popat, M. Reck, J. Andrade, A. Becker, D. Moro-Sibilot, A. Curioni-Fontecedro, O. Molinier, K. Nackaerts, A. Insa Mollá, R. Gervais, G. López Vivanco, J. Madelaine, J. Mazieres, M. Faehling, F. Griesinger, M. Majem, J.L. González Larriba, M. Provencio Pulla, K. Vervita, H. Roschitzki-Voser, B. Ruepp, P. Mitchell, R.A. Stahel, C. Le Pechoux, D. De Ruysscher, R. Stahel, A. Hiltbrunner, M. Pardo-Contreras, A. Gasca-Ruchti, N. Giacomelli, R. Kammler, N. Marti, R. Pfister, A.C. Piguet, S. Roux, S. Troesch, M. Schneider, R. Schweri, I. Zigomo, Z. Tsourti, P. Zygoura, S. Tsouprou, M. Kassapian, G. Dimopoulou, C. Andriakopoulou, F. Morin, E. Amour, G. Mariaule, N. Archirel, M. Fernandez, E. Pereira, L. Benito, K. Lopez, A. Hernández, S. Chinchen, H. Jurkovic, A. Livingstone, J. Mitchell, M. Walker, S. Ng, C. Steer, K. Briscoe, A. Saqib, E. Abdi, B. Houghton, K. O’Byrne, B.R. Chittajallu, B.G. Hughes, A. Black, H. Werner, G. Zalcman, F. Vaylet, P. Merle, I. Monnet, N. Girard, P.-J. Souquet, F. Barlesi, D. Debieuvre, H. Senellart, M. Poudenx, A. Dixmier, D. Pouessel, J. Cadranel, H. Lena, E. Quoix, S. Friard, C. Audigier-Valette, E. Pichon, K. Kokowski, H. Kirchen, A. Tufman, C. De-Colle, J. de Langen, A. Insa, B. Massutí, M.P. Pulla, S.P. Aix, N. Villanueva, G.L. Vivanco, K. Franks, R. Califano

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Pulmonary medicine, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, University of Zurich, Stahel, R A

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
ETOP/IFCT 4-12 STIMULI Collaborators 2022, ' Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial ', Annals of Oncology, vol. 33, no. 1, pp. 67-79 . https://doi.org/10.1016/j.annonc.2021.09.011
Annals of Oncology, 33(1), 67-79. Oxford University Press

مصطلحات موضوعية: Male, medicine.medical_specialty, Lung Neoplasms, 2720 Hematology, MULTICENTER, 610 Medicine & health, Ipilimumab, Randomised clinical trial, randomised clinical trial, 1ST-LINE NIVOLUMAB, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, small-cell lung cancer, Humans, RECURRENT, ipilimumab, Lung cancer, nivolumab, Limited disease, Performance status, Small cell lung cancer, business.industry, Standard treatment, Hazard ratio, PLUS IPILIMUMAB, SCLC, Hematology, Chemoradiotherapy, Middle Aged, medicine.disease, OPEN-LABEL, Nivolumab, Oncology, 10032 Clinic for Oncology and Hematology, limited disease, CHECKMATE 032, 2730 Oncology, Female, Prophylactic cranial irradiation, business, medicine.drug

وصف الملف: Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c0cd2636f83c5b87a3871c7a3d45ee
https://lirias.kuleuven.be/handle/123456789/682788

المؤلفون: Xavier Mignard, Bertrand Mennecier, Marie Wislez, Radj Gervais, Martine Antoine, Gérard Zalcman, Bernard Milleron, Denis Moro-Sibilot, Franck Morin, E. Amour, Charles Dayen

المصدر: Revue des Maladies Respiratoires. 35:983-988

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Gynecology, medicine.medical_specialty, Durvalumab, business.industry, Anti pd 1, Neo adjuvant, medicine.disease, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Immune system, 030220 oncology & carcinogenesis, medicine, 030212 general & internal medicine, Non small cell, Stage (cooking), Lung cancer, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e873bcf49b3034922c6afd239d452cec
https://doi.org/10.1016/j.rmr.2018.08.006

المؤلفون: Philippe Masson, Denis Moro-Sibilot, Isabelle Monnet, Anne-Claire Toffart, Bertrand Mennecier, Didier Debieuvre, E. Amour, Eric Pichon, Fabrice Barlesi, Olivier Molinier, Franck Morin, Patrick Aldo Renault, Anne Madroszyk-Flandin, Séverine Fraboulet, Isabelle Rouquette, Alexis B. Cortot, Pierre Jean Souquet, Virginie Westeel, Sandrine Hiret, Clarisse Audigier-Valette, Julien Mazieres, Benjamin Besse, Gérard Zalcman

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 26(13)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, law.invention, 03 medical and health sciences, 0302 clinical medicine, Gefitinib, Randomized controlled trial, Estrogen Receptor Modulators, law, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Biomarkers, Tumor, Humans, Lung cancer, neoplasms, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Aged, 80 and over, Fulvestrant, business.industry, Middle Aged, Antiestrogen, medicine.disease, Prognosis, respiratory tract diseases, Clinical trial, ErbB Receptors, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Mutation, Female, Erlotinib, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ecbc189802ce70dfbd0a491c5fd17cc
https://pubmed.ncbi.nlm.nih.gov/32144133

المؤلفون: Julien Mazieres, Pascal Do, Gérard Zalcman, O. Bylicki, Jacques Cadranel, Sylvie Lantuejoul, Franck Morin, Florian Guisier, Laurent Greillier, David Planchard, Olivier Molinier, Clarisse Audigier-Valette, Didier Debieuvre, Catherine Ligeza-poisson, M. Locatelli-Sanchez, Romain Corre, Delphine Carmier, Thierry Urban, Isabelle Monnet, Denis Moro-Sibilot, E. Amour, Arnaud Scherpereel, Sandrine Hiret, Séverine Fraboulet-Moreau

المساهمون: Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Université Le Havre Normandie (ULH), Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Université Le Havre Normandie (ULH), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)

المصدر: The Lancet Oncology
The Lancet Oncology, 2019, 20 (2), pp.239-253. ⟨10.1016/S1470-2045(18)30765-4⟩

مصطلحات موضوعية: Adult, Male, Mesothelioma, 0301 basic medicine, medicine.medical_specialty, Lung Neoplasms, Combination therapy, Pleural Neoplasms, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Population, Ipilimumab, Gastroenterology, law.invention, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, education, Aged, Aged, 80 and over, education.field_of_study, Chemotherapy, business.industry, Mesothelioma, Malignant, Middle Aged, medicine.disease, 3. Good health, respiratory tract diseases, Nivolumab, 030104 developmental biology, Pemetrexed, Oncology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae99b54465162f6dcacf656787abcc08
https://hal.archives-ouvertes.fr/hal-02570690

المؤلفون: X, Mignard, M, Antoine, D, Moro-Sibilot, C, Dayen, B, Mennecier, R, Gervais, E, Amour, B, Milleron, F, Morin, G, Zalcman, M, Wislez

المساهمون: Theranoscan [CHU Tenon] (GRC 4), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Service d’Anatomie et cytologie pathologiques [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Intergroupe Francophone de Cancérologie Thoracique [Paris] (IFCT), Intergroupe Francophone de Cancérologie thoracique, Centre Hospitalier Universitaire [Grenoble] (CHU), CHU Strasbourg, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Service d’oncologie thoracique et essais précoces [CHU Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Pneumologie - Oncologie Thoracique - Maladies Pulmonaires Rares [CHU Tenon], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

المصدر: Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, Elsevier Masson, 2018, 35 (9), pp.983-988. ⟨10.1016/j.rmr.2018.08.006⟩

مصطلحات موضوعية: Adult, Lung Neoplasms, Adolescent, [SDV]Life Sciences [q-bio], NSCLC, Anti-PD-L1, Young Adult, Antineoplastic Agents, Immunological, Carcinoma, Non-Small-Cell Lung, Stade précoce, Humans, Pneumonectomy, Aged, Neoplasm Staging, Aged, 80 and over, Néo-adjuvant, CBNPC, Early stage, Antibodies, Monoclonal, Middle Aged, Combined Modality Therapy, Neoadjuvant Therapy, Research Design, Preoperative Period, Feasibility Studies, France, Immunotherapy, Durvalumab, Neoadjuvant

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4025ff3aea2b46c610546263bca8bf07
https://hal.sorbonne-universite.fr/hal-01974491

المؤلفون: Didier Debieuvre, Anne-Claire Toffart, P.J. Souquet, G. Zalcman, J. Mazieres, Olivier Molinier, C. Dayen, Franck Morin, E. Giroux Leprieur, Eric Pichon, L. Thibonnier, N. Cloarec, S. Van Hulst, P. Masson, T. Egenod, E. Amour, A.-C. Madroszyk Flandin, L. Favier, Adrien Dixmier

المصدر: Annals of Oncology. 30:v658

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Ipilimumab, Hematology, Chemotherapy regimen, Discontinuation, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Clinical endpoint, Progression-free survival, Nivolumab, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::467e55f2097e2927fa24e8bc7e5256fc
https://doi.org/10.1093/annonc/mdz260.113

المؤلفون: Olivier Molinier, J. Mazieres, Thierry Urban, D. Moro-Sibilot, Sylvie Lantuejoul, G. Zalcman, Franck Morin, C. Ligeza-Poisson, Solenn Brosseau, Isabelle Monnet, M. Locatelli-Sanchez, Arnaud Scherpereel, Laurent Greillier, Romain Corre, Florian Guisier, O. Bylicki, David Planchard, P. Do, E. Amour, Clarisse Audigier-Valette

المصدر: Annals of Oncology. 30:v747

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Pleural mesothelioma, business.industry, Disease progression, Mediolanum, Hematology, Long term results, Disease control, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, Third line, 030220 oncology & carcinogenesis, Visual accommodation, Internal medicine, medicine, Tumor growth, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8f7908ba7f707ca79048ed18597f83a3
https://doi.org/10.1093/annonc/mdz266

المؤلفون: Julien Mazieres, Denis Moro-Sibilot, Pascal Do, David Planchard, Catherine Ligeza-poisson, Luc Thiberville, O. Bylicki, E. Amour, Clarisse Audigier-Valette, Arnaud Scherpereel, Franck Morin, Romain Corre, Olivier Molinier, Thierry Urban, M. Locatelli-Sanchez, Gérard Zalcman, Laurent Greillier, Isabelle Monnet

المساهمون: Service de pneumologie, oncologie thoracique et soins intensifs respiratoires [Rouen], Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Université Le Havre Normandie (ULH), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Université Le Havre Normandie (ULH), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA), Breton, Céline, Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Hôpital Charles Nicolle [Rouen]-CHU Rouen

المصدر: Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Ipilimumab, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Clinical endpoint, Medicine, ComputingMilieux_MISCELLANEOUS, business.industry, Pleural mesothelioma, Disease control, 3. Good health, Surgery, [SDV] Life Sciences [q-bio], 030104 developmental biology, Pemetrexed, Oncology, Third line, 030220 oncology & carcinogenesis, Nivolumab, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f85faca7f515b429caf0136a70d8a4b1
https://hal.archives-ouvertes.fr/hal-01676507

المؤلفون: Didier Debieuvre, P.J. Souquet, Virginie Westeel, S. Moreau, G. Zalcman, P. Masson, Aldo Renault, J. Mazieres, Franck Morin, Fabrice Barlesi, Isabelle Monnet, A. Madroszyk, Denis Moro-Sibilot, Clarisse Audigier-Valette, Isabelle Rouquette, Anne-Claire Toffart, Benjamin Besse, E. Amour, Sandrine Hiret, Bertrand Mennecier

المصدر: Journal of Thoracic Oncology. 13:S487

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Egfr tki, Non squamous, business.industry, Internal medicine, Advanced stage, medicine, Anti estrogen, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::463808390f9cb2d772d8afc207c43f50
https://doi.org/10.1016/j.jtho.2018.08.622